Author:
Pittaway Harriet,Grudzinska Frances,Livesey Alana,Quarton Samuel,Adiga Aditya,Dosanjh Davinder,Parekh Dhruv
Funder
National Institute for Health and Care Research
Birmingham Biomedical Research Centre
AstraZeneca
Dunhill Medical Trust
NIHR Imperial Biomedical Research Centre
University of Birmingham
Reference87 articles.
1. Empiric antibiotic therapy for suspected ventilator-associated pneumonia: A systematic review and meta-analysis of randomized trials;Aarts;Crit Care Med.,2008
2. A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia;Awad;Clinical Infectious Diseases.,2014
3. An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity;Baer;Infect Immun.,2009
4. Barberán J. Possible clinical indications of ceftobiprole. Vol. 32, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia. 2019.
5. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial;Bassetti;Lancet Infect Dis.,2021